Taïeb, David
Hicks, Rodney J.
Hindié, Elif
Guillet, Benjamin A.
Avram, Anca
Ghedini, Pietro
Timmers, Henri J.
Scott, Aaron T.
Elojeimy, Saeed
Rubello, Domenico
Virgolini, Irène J.
Fanti, Stefano
Balogova, Sona
Pandit-Taskar, Neeta
Pacak, Karel
Article History
Received: 4 June 2019
Accepted: 10 June 2019
First Online: 29 June 2019
Compliance with Ethical Standards
:
: RH has received research funding from Ipsen, Novartis, and Clarity Pharmaceuticals and holds stock in Telix Pharmaceuticals on behalf of his institution.NPT has received consultant/advisory board/honoraria (current/past) from Y-mAbs, Progenics, Bayer, and MedImmune/AstraZeneca and sponsored trials/research support from ImaginAb, Genentech, and Actinium Pharma/FluoroPharma.The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human participants performed by any of the authors.